Advertisement
CRL vs IRTC
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a StrongBuy and IRTC is a StrongBuy.
CRL's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for CRL turned positive on October 20, 2026. Looking at past instances where CRL's MACD turned positive, the stock continued to rise in 37 of 48 cases over the following month. The odds of a continued upward trend are 77%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CRL as a result. In 55 of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
Following a +4.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRL advanced for three days, in 198 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
The Aroon Indicator entered an Uptrend today. In 150 of 228 cases where CRL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
CRL broke above its upper Bollinger Band on October 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 2 (best 1 - 100 worst), indicating outstanding price growth. CRL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.287) is normal, around the industry mean (66.330). P/E Ratio (-77.751) is within average values for comparable stocks, (2.659). Projected Growth (PEG Ratio) (0.122) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (3.340) is also within normal values, averaging (9.775).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
IRTC's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for IRTC turned positive on October 15, 2026. Looking at past instances where IRTC's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 19, 2026. You may want to consider a long position or call options on IRTC as a result. In 69 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 79%.
IRTC moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for IRTC crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.
Following a +1.69% 3-day Advance, the price is estimated to grow further. Considering data from situations where IRTC advanced for three days, in 255 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IRTC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
IRTC broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for IRTC entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 3 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.651) is normal, around the industry mean (3.824). IRTC's P/E Ratio (-304.286) is considerably lower than the industry average of (1.677). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (4.398) is also within normal values, averaging (40.124).
The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 52 (best 1 - 100 worst), indicating steady price growth. IRTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 55 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 62 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CRL | IRTC | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 32 | 10 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 3 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 62 | |
SMR RATING 1..100 | 93 | 93 | |
PRICE GROWTH RATING 1..100 | 2 | 52 | |
P/E GROWTH RATING 1..100 | 93 | 55 | |
SEASONALITY SCORE 1..100 | 50 | 12 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IRTC's Valuation (3) in the Medical Specialties industry is in the same range as CRL (15) in the Miscellaneous Commercial Services industry. This means that IRTC’s stock grew similarly to CRL’s over the last 12 months.
IRTC's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for CRL (100) in the Miscellaneous Commercial Services industry. This means that IRTC’s stock grew somewhat faster than CRL’s over the last 12 months.
IRTC's SMR Rating (93) in the Medical Specialties industry is in the same range as CRL (93) in the Miscellaneous Commercial Services industry. This means that IRTC’s stock grew similarly to CRL’s over the last 12 months.
CRL's Price Growth Rating (2) in the Miscellaneous Commercial Services industry is somewhat better than the same rating for IRTC (52) in the Medical Specialties industry. This means that CRL’s stock grew somewhat faster than IRTC’s over the last 12 months.
IRTC's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for CRL (93) in the Miscellaneous Commercial Services industry. This means that IRTC’s stock grew somewhat faster than CRL’s over the last 12 months.
| CRL | IRTC | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 73% | 2 days ago 88% |
| Stochastic ODDS (%) | 2 days ago 79% | 2 days ago 80% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 88% |
| TrendWeek ODDS (%) | 2 days ago 69% | 2 days ago 78% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 80% |
| Advances ODDS (%) | 2 days ago 70% | 2 days ago 79% |
| Declines ODDS (%) | 11 days ago 70% | 22 days ago 80% |
| BollingerBands ODDS (%) | 2 days ago 78% | 2 days ago 70% |
| Aroon ODDS (%) | 2 days ago 66% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CRL’s FA Score shows that 2 FA rating(s) are green while IRTC’s FA Score has 1 green FA rating(s).
- CRL’s FA Score: 2 green, 3 red.
- IRTC’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CRL’s TA Score shows that 4 TA indicator(s) are bullish while IRTC’s TA Score has 5 bullish TA indicator(s).
- CRL’s TA Score: 4 bullish, 4 bearish.
- IRTC’s TA Score: 5 bullish, 5 bearish.
Price Growth
CRL (@Medical Specialties) experienced а +8.44% price change this week, while IRTC (@Medical/Nursing Services) price change was +9.19% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +4.87%. For the same industry, the average monthly price growth was -2.23%, and the average quarterly price growth was +53.00%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.46%. For the same industry, the average monthly price growth was -5.07%, and the average quarterly price growth was -5.06%.
Reported Earning Dates
CRL is expected to report earnings on Nov 04, 2026.
IRTC is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Medical Specialties (+4.87% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (+2.46% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
IRTC and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRTC has been loosely correlated with STE. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IRTC jumps, then STE could also see price increases.
| Ticker / NAME | Correlation To IRTC | 1D Price Change % | ||
|---|---|---|---|---|
| IRTC | 100% | +0.19% | ||
| STE - IRTC | 45% Loosely correlated | +0.13% | ||
| GEHC - IRTC | 41% Loosely correlated | +6.62% | ||
| INGN - IRTC | 39% Loosely correlated | +1.68% | ||
| SYK - IRTC | 39% Loosely correlated | +0.86% | ||
| CNMD - IRTC | 38% Loosely correlated | -3.05% | ||
More | ||||